468 related articles for article (PubMed ID: 33669846)
21. Proteasomal degradation of TRIM5alpha during retrovirus restriction.
Rold CJ; Aiken C
PLoS Pathog; 2008 May; 4(5):e1000074. PubMed ID: 18497858
[TBL] [Abstract][Full Text] [Related]
22. A TRIM5alpha-independent post-entry restriction to HIV-1 infection of macaque cells that is dependent on the path of entry.
Pineda MJ; Orton BR; Overbaugh J
Virology; 2007 Jul; 363(2):310-8. PubMed ID: 17350067
[TBL] [Abstract][Full Text] [Related]
23. Genetic association of the antiviral restriction factor TRIM5alpha with human immunodeficiency virus type 1 infection.
Speelmon EC; Livingston-Rosanoff D; Li SS; Vu Q; Bui J; Geraghty DE; Zhao LP; McElrath MJ
J Virol; 2006 Mar; 80(5):2463-71. PubMed ID: 16474153
[TBL] [Abstract][Full Text] [Related]
24. Human immunodeficiency virus type 1 restriction by human-rhesus chimeric tripartite motif 5alpha (TRIM 5alpha) in CD34(+) cell-derived macrophages in vitro and in T cells in vivo in severe combined immunodeficient (SCID-hu) mice transplanted with human fetal tissue.
Anderson J; Akkina R
Hum Gene Ther; 2008 Mar; 19(3):217-28. PubMed ID: 18279037
[TBL] [Abstract][Full Text] [Related]
25. [Cellular and antiviral functions of TRIM5α].
Khalfi S; Mérindol N; Berthoux L
Virologie (Montrouge); 2020 Dec; 24(6):369-380. PubMed ID: 33441289
[TBL] [Abstract][Full Text] [Related]
26. Cyclophilin A and TRIM5alpha independently regulate human immunodeficiency virus type 1 infectivity in human cells.
Sokolskaja E; Berthoux L; Luban J
J Virol; 2006 Mar; 80(6):2855-62. PubMed ID: 16501094
[TBL] [Abstract][Full Text] [Related]
27. Human TRIM5α senses and restricts LINE-1 elements.
Volkmann B; Wittmann S; Lagisquet J; Deutschmann J; Eissmann K; Ross JJ; Biesinger B; Gramberg T
Proc Natl Acad Sci U S A; 2020 Jul; 117(30):17965-17976. PubMed ID: 32651277
[TBL] [Abstract][Full Text] [Related]
28. TRIM5α Restricts Flavivirus Replication by Targeting the Viral Protease for Proteasomal Degradation.
Chiramel AI; Meyerson NR; McNally KL; Broeckel RM; Montoya VR; Méndez-Solís O; Robertson SJ; Sturdevant GL; Lubick KJ; Nair V; Youseff BH; Ireland RM; Bosio CM; Kim K; Luban J; Hirsch VM; Taylor RT; Bouamr F; Sawyer SL; Best SM
Cell Rep; 2019 Jun; 27(11):3269-3283.e6. PubMed ID: 31189110
[TBL] [Abstract][Full Text] [Related]
29. Visualization of a proteasome-independent intermediate during restriction of HIV-1 by rhesus TRIM5alpha.
Campbell EM; Perez O; Anderson JL; Hope TJ
J Cell Biol; 2008 Feb; 180(3):549-61. PubMed ID: 18250195
[TBL] [Abstract][Full Text] [Related]
30. Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor.
Stremlau M; Perron M; Lee M; Li Y; Song B; Javanbakht H; Diaz-Griffero F; Anderson DJ; Sundquist WI; Sodroski J
Proc Natl Acad Sci U S A; 2006 Apr; 103(14):5514-9. PubMed ID: 16540544
[TBL] [Abstract][Full Text] [Related]
31. HIV Restriction Factors and Mechanisms of Evasion.
Malim MH; Bieniasz PD
Cold Spring Harb Perspect Med; 2012 May; 2(5):a006940. PubMed ID: 22553496
[TBL] [Abstract][Full Text] [Related]
32. Human cellular restriction factors that target HIV-1 replication.
Strebel K; Luban J; Jeang KT
BMC Med; 2009 Sep; 7():48. PubMed ID: 19758442
[TBL] [Abstract][Full Text] [Related]
33. Effects of human TRIM5alpha polymorphisms on antiretroviral function and susceptibility to human immunodeficiency virus infection.
Javanbakht H; An P; Gold B; Petersen DC; O'Huigin C; Nelson GW; O'Brien SJ; Kirk GD; Detels R; Buchbinder S; Donfield S; Shulenin S; Song B; Perron MJ; Stremlau M; Sodroski J; Dean M; Winkler C
Virology; 2006 Oct; 354(1):15-27. PubMed ID: 16887163
[TBL] [Abstract][Full Text] [Related]
34. Contribution of RING domain to retrovirus restriction by TRIM5alpha depends on combination of host and virus.
Maegawa H; Miyamoto T; Sakuragi J; Shioda T; Nakayama EE
Virology; 2010 Apr; 399(2):212-20. PubMed ID: 20110098
[TBL] [Abstract][Full Text] [Related]
35. TRIM5α restriction affects clinical outcome and disease progression in simian immunodeficiency virus-infected rhesus macaques.
Wu F; Ourmanov I; Riddick N; Matsuda K; Whitted S; Plishka RJ; Buckler-White A; Starost MF; Hirsch VM
J Virol; 2015 Feb; 89(4):2233-40. PubMed ID: 25473059
[TBL] [Abstract][Full Text] [Related]
36. HIV Exploits Antiviral Host Innate GCN2-ATF4 Signaling for Establishing Viral Replication Early in Infection.
Jiang G; Santos Rocha C; Hirao LA; Mendes EA; Tang Y; Thompson GR; Wong JK; Dandekar S
mBio; 2017 May; 8(3):. PubMed ID: 28465428
[TBL] [Abstract][Full Text] [Related]
37. The cell biology of TRIM5α.
Lukic Z; Campbell EM
Curr HIV/AIDS Rep; 2012 Mar; 9(1):73-80. PubMed ID: 22193888
[TBL] [Abstract][Full Text] [Related]
38. TRIM E3 ligases in HIV infection: can these intrinsic immunity factors be harnessed for novel vaccines or therapies?
Ndung'u T
Virulence; 2011; 2(4):360-6. PubMed ID: 21758007
[TBL] [Abstract][Full Text] [Related]
39. p62/sequestosome-1 associates with and sustains the expression of retroviral restriction factor TRIM5alpha.
O'Connor C; Pertel T; Gray S; Robia SL; Bakowska JC; Luban J; Campbell EM
J Virol; 2010 Jun; 84(12):5997-6006. PubMed ID: 20357094
[TBL] [Abstract][Full Text] [Related]
40. Viral attachment induces rapid recruitment of an innate immune sensor (TRIM5α) to the plasma membrane.
Ohmine S; Singh RD; Marks DL; Meyer MA; Pagano RE; Ikeda Y
J Innate Immun; 2013; 5(4):414-24. PubMed ID: 23548691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
